Clinigen Group Stock Price, News & Analysis (OTCMKTS:CLIGF)

$13.90 +0.95 (+7.34 %)
(As of 02/21/2018 04:35 AM ET)
Previous Close$12.95
Today's Range$13.90 - $13.90
52-Week Range$12.20 - $13.90
Volume3,600 shs
Average Volume2,400 shs
Market Capitalization$1.80 billion
P/E RatioN/A
Dividend YieldN/A
Beta-0.95

About Clinigen Group (OTCMKTS:CLIGF)

Clinigen Group logo

Receive CLIGF News and Ratings via Email

Sign-up to receive the latest news and ratings for CLIGF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:CLIGF
CUSIPN/A
Phone01283 495010

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$383.41 million
Price / Sales4.17
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees465
Outstanding Shares115,090,000

Clinigen Group (OTCMKTS:CLIGF) Frequently Asked Questions

What is Clinigen Group's stock symbol?

Clinigen Group trades on the OTCMKTS under the ticker symbol "CLIGF."

Who are some of Clinigen Group's key competitors?

How do I buy Clinigen Group stock?

Shares of Clinigen Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Clinigen Group's stock price today?

One share of Clinigen Group stock can currently be purchased for approximately $13.90.

How big of a company is Clinigen Group?

Clinigen Group has a market capitalization of $1.80 billion and generates $383.41 million in revenue each year. Clinigen Group employs 465 workers across the globe.

How can I contact Clinigen Group?

Clinigen Group's mailing address is PITCAIRN HOUSE CROWN SQUARE FIRST AVENUE, STAFFORDSHIRE X0, D E14 2W W. The company can be reached via phone at 01283 495010.


MarketBeat Community Rating for Clinigen Group (CLIGF)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  94
MarketBeat's community ratings are surveys of what our community members think about Clinigen Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Clinigen Group (OTCMKTS:CLIGF) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Clinigen Group (OTCMKTS:CLIGF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Clinigen Group (OTCMKTS:CLIGF) Earnings Estimates

Current Year EPS Consensus Estimate: $0.63 EPS
Next Year EPS Consensus Estimate: $0.69 EPS

Dividends

Dividend History for Clinigen Group (OTCMKTS:CLIGF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Clinigen Group (OTCMKTS CLIGF)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Clinigen Group (OTCMKTS CLIGF) News Headlines

Source:
DateHeadline
Strategic Equity Capital Outperforms Benchmark In First HalfStrategic Equity Capital Outperforms Benchmark In First Half
www.morningstar.co.uk - February 13 at 8:06 AM
Zacks Investment Research Lowers Clinigen Gp (CLIGF) to HoldZacks Investment Research Lowers Clinigen Gp (CLIGF) to Hold
www.americanbankingnews.com - November 28 at 7:50 PM

SEC Filings

Clinigen Group (OTCMKTS:CLIGF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Clinigen Group (OTCMKTS CLIGF) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.